Last quarter (Q3 2023), Jazz Pharmaceuticals's total revenue was $972.14M, an increase of 3.35% from the same quarter last year. In Q3, Jazz Pharmaceuticals's net income was $146.82M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 3.78B	$ 3.66B	$ 3.09B	$ 2.36B	$ 2.16B	$ 1.89B
Cost of Revenue	$ 96.32M	$ -540.52M	$ 440.76M	$ 148.92M	$ 127.93M	$ 121.54M
Gross Profit	$ 3.70B	$ 4.20B	$ 2.65B	$ 2.21B	$ 2.03B	$ 1.77B
Operating Expense	$ 3.11B	$ 3.05B	$ 2.48B	$ 1.70B	$ 1.50B	$ 1.11B
Operating Income	$ 387.77M	$ -65.53M	$ 170.28M	$ 514.21M	$ 532.37M	$ 657.73M
Net Non Operating Interest Income Expense	$ -293.24M	$ -288.24M	$ -278.77M	$ -99.71M	$ -72.26M	$ -78.50M
Other Income Expense	$ 3.32M	$ 9.92M	$ 714.00K	$ -139.41M	$ -5.81M	$ -49.77M
Pretax Income	$ -104.59M	$ -372.78M	$ -112.84M	$ 275.10M	$ 454.30M	$ 529.46M
Tax Provision	$ -186.87M	$ -158.65M	$ 216.12M	$ 33.52M	$ -73.15M	$ 80.16M
Earnings From Equity Interest Net Of Tax	$ -3.32M	$ -9.92M	$ -714.00K	$ -2.96M	$ -4.09M	$ -2.20M
Net Income Common Stockholders	$ 79.95M	$ 856.97M	$ -329.67M	$ 238.62M	$ 523.37M	$ 447.10M
Basic EPS	$ 1.19	$ -3.58	$ -5.52	$ 4.28	$ 9.22	$ 7.45
Diluted EPS	$ 0.85	$ -3.58	$ -5.52	$ 4.22	$ 9.09	$ 7.30
Basic Average Shares	$ 253.14M	$ 62.54M	$ 59.69M	$ 55.71M	$ 56.75M	$ 59.98M
Diluted Average Shares	$ 281.14M	$ 62.54M	$ 59.69M	$ 56.52M	$ 57.55M	$ 61.22M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	$ 12.46	$ 16.23	$ 13.70
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 3.20B	$ 2.51B	$ 2.92B	$ 1.85B	$ 1.63B	$ 1.23B
Net Income From Continuing And Discontinued Operation	$ 79.95M	$ -224.06M	$ -329.67M	$ 238.62M	$ 523.37M	$ 447.10M
Normalized Income	$ 109.80M	$ -410.71M	-	$ 361.02M	$ 527.61M	$ 489.35M
Interest Expense	-	-	-	$ 99.71M	$ 72.26M	$ 78.50M
EBIT	$ -30.47M	$ -339.98M	$ -202.74M	$ 374.80M	$ 526.56M	$ 607.96M
EBITDA	$ 586.41M	$ 289.49M	$ 349.75M	$ 653.05M	$ 896.72M	$ 824.69M

Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing